The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Efficacy of the Novel Antidepressant Agomelatine on the Circadian Rest-Activity Cycle and Depressive and Anxiety Symptoms in Patients With Major Depressive Disorder: A Randomized, Double-Blind Comparison With Sertraline
Abstract
OBJECTIVE: This study evaluates the efficacy of agomelatine, the first antidepressant to be an agonist at MT(1)/MT(2) receptors and an antagonist at 5-HT(2C) receptors, versus sertraline with regard to the amplitude of the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder (MDD). METHOD: Outpatients with DSM-IV-TR-defined MDD received either agomelatine 25 to 50 mg (n = 154) or sertraline 50 to 100 mg (n = 159) during a 6-week, randomized, double-blind treatment period. The study was conducted from 2005 to 2006. The main outcome measure was the relative amplitude of the individual rest-activity cycles, expressed as change from baseline to week 6 and collected from continuous records using wrist actigraphy and sleep logs. Secondary outcome measures were sleep efficiency and sleep latency, both derived from actigraphy, and efficacy on depression symptoms (17-Item Hamilton Depression Rating Scale total score and Clinical Global Impressions scale scores) and anxiety symptoms (Hamilton Anxiety Rating Scale total score and subscores). RESULTS: A significant difference in favor of agomelatine compared to sertraline on the relative amplitude of the circadian rest-activity cycle was observed at the end of the first week (P = .01). In parallel, a significant improvement of sleep latency (P <.001) and sleep efficiency (P <.001) from week 1 to week 6 was observed with agomelatine as compared to sertraline. Over the 6-week treatment period, depressive symptoms improved significantly more with agomelatine than with sertraline (P <.05), as did anxiety symptoms (P <.05). CONCLUSIONS: The favorable effect of agomelatine on the relative amplitude of the circadian rest-activity/sleep-wake cycle in depressed patients at week 1 reflects early improvement in sleep and daytime functioning. Higher efficacy results were observed with agomelatine as compared to sertraline on both depressive and anxiety symptoms over the 6-week treatment period, together with a good tolerability profile. These findings indicate that agomelatine offers promising benefits for MDD patients. TRIAL REGISTRATION: www.isrctn.org: ISRCTN49376288.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
(1976) · Medical Entomology and Zoology · Cited by 8,899
A sharper Bonferroni procedure for multiple tests of significance
HOCHBERG, Y. (1988) · Biometrika · doi:10.1093/biomet/75.4.800 · Cited by 4,829
The Role of Actigraphy in the Study of Sleep and Circadian Rhythms
Ancoli-Israel, S., Cole, R., Alessi, C., Chambers, M., Moorcroft, W., & Pollak, C. P. (2003) · Sleep · doi:10.1093/sleep/26.3.342 · Cited by 2,751 · cited 1×
“The miniaturized wrist-worn devices used in this study allowed ambulatory measurements for several weeks in the patient’s natural environment with minimal interference in the everyday lifestyle.(32) In sleep research and chronobiology, actigraphy has proved useful as a method to indirectly measure sleep and characteri…”
MethodSheehan, D., Lecrubier, Y., Harnett Sheehan, K., Janavs, J., Weiller, E., Keskiner, A., Schinka, J., Knapp, E., Sheehan, M., & Dunbar, G. (1997) · European Psychiatry · doi:10.1016/s0924-9338(97)83297-x · Cited by 2,149
The Role of Actigraphy in the Evaluation of Sleep Disorders
Sadeh, A., Hauri, P. J., Kripke, D. F., & Lavie, P. (1995) · Sleep · doi:10.1093/sleep/18.4.288 · Cited by 909
Circadian rhythm disturbances in depression
Germain, A., & Kupfer, D. J. (2008) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.964 · Cited by 644
Judd, L. L., Akiskal, H. S., Maser, J. D., Zeller, P. J., Endicott, J., Coryell, W., Paulus, M. P., Kunovac, J. L., Leon, A. C., Mueller, T. I., et al. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00138-4 · Cited by 590
Millan, M. J., Gobert, A., Lejeune, F., Dekeyne, A., Newman-Tancredi, A., Pasteau, V., Rivet, J.-M., & Cussac, D. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.051797 · Cited by 516
Bech, P., Gram, L. F., Dein, E., Jacobsen, O., Vitger, J., & Bolwig, T. G. (1975) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1975.tb00002.x · Cited by 489
Bauer, M., Bschor, T., Pfennig, A., Whybrow, P. C., Angst, J., Versiani, M., Möller, H.-J., WFSBP Task Force on Unipolar Depres, Bauer, M., Bschor, T., et al. (2007) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701227829 · Cited by 477
Antidepressants and Sleep: A Qualitative Review of the Literature
Wilson, S., & Argyropoulos, S. (2005) · Drugs · doi:10.2165/00003495-200565070-00003 · Cited by 392
L??o, H., Hale, A., & D??haenen, H. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200209000-00004 · Cited by 361
Goodwin, G. M., Emsley, R., Rembry, S., Rouillon, F., & the Agomelatine Study Group (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04548 · Cited by 340
Antidepressants and their effect on sleep
Mayers, A. G., & Baldwin, D. S. (2005) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.726 · Cited by 323
Sleep Disturbance and Depression Recurrence in Community-Dwelling Older Adults: A Prospective Study
Cho, H. J., Lavretsky, H., Olmstead, R., Levin, M. J., Oxman, M. N., & Irwin, M. R. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07121882 · Cited by 321
Placebo-controlled trial of agomelatine in the treatment of major depressive disorder
Kennedy, S. H., & Emsley, R. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.09.002 · Cited by 294
Effect of Agomelatine in the Chronic Mild Stress Model of Depression in the Rat
Papp, M., Gruca, P., Boyer, P.-A., & Mocaër, E. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300091 · Cited by 268
Pierre Olié, J., & Kasper, S. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007766 · Cited by 256
Self-citationBenca, R. M., & Peterson, M. J. (2008) · Sleep Medicine · doi:10.1016/s1389-9457(08)70010-8 · Cited by 249
Factor analysis of a sleep evaluation questionnaire
Parrott, A. C., & Hindmarch, I. (1978) · Psychological Medicine · doi:10.1017/s0033291700014379 · Cited by 238
Novel naphthalenic ligands with high affinity for the melatonin receptor
Yous, S., Andrieux, J., Howell, H. E., Morgan, P. J., Renard, P., Pfeiffer, B., Lesieur, D., & Guardiola-Lemaitre, B. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00086a018 · Cited by 234
Lemoine, P., & Guilleminault, C. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n1112 · Cited by 217
Kennedy, S. H., Rizvi, S., Fulton, K., & Rasmussen, J. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318172b48c · Cited by 212
Antidepressant treatment of the depressed patient with insomnia.
Thase, M. E. (1999) · PubMed · Cited by 205
Krauchi, K., Cajochen, C., Mori, D., Graw, P., & Wirz-Justice, A. (1997) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1997.272.4.r1178 · Cited by 196
Self-citationAlterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression
Zhou, J.-N., Riemersma, R. F., Unmehopa, U. A., Hoogendijk, W. J. G., van Heerikhuize, J. J., Hofman, M. A., & Swaab, D. F. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.7.655 · Cited by 172
Self-citationMajor depressive disorder, sleep EEG and agomelatine: an open-label study
Salva, M.-A. Q., Vanier, B., Laredo, J., Hartley, S., Chapotot, F., Moulin, C., Lofaso, F., & Guilleminault, C. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007754 · Cited by 170
Korszun, A., Young, E. A., Engleberg, N. C., Brucksch, C. B., Greden, J. F., & Crofford, L. J. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(01)00237-9 · Cited by 148
Zisapel, N., & Nir, T. (2003) · Journal of Sleep Research · doi:10.1046/j.0962-1105.2003.00365.x · Cited by 138
Subjective Well-Being Is Modulated by Circadian Phase, Sleep Pressure, Age, and Gender
Birchler-Pedross, A., Schroder, C. M., Münch, M. Y., Knoblauch, V., Blatter, K., Schnitzler-Sack, C., Wirz‐Justice, A., & Cajochen, C. (2009) · Journal of Biological Rhythms · doi:10.1177/0748730409335546 · Cited by 129
Self-citationAntidepressant drugs can slow or dissociate circadian rhythms
Wirz-Justice, A., & Campbell, I. C. (1982) · Experientia · doi:10.1007/bf01954918 · Cited by 128
Self-citationKasper, S. F., & Hamon, M. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970902717024 · Cited by 127
Self-citationRaoux, N., Benoit, O., Dantchev, N., Denise, P., Franc, B., Alliale, J.-F., & Widlöcher, D. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90122-8 · Cited by 123
Motor activity and autonomic cardiac functioning in major depressive disorder
Volkers, A. C. W., Tulen, J. H. M., van den Broek, W. W., Bruijn, J. A., Passchier, J., & Pepplinkhuizen, L. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00066-6 · Cited by 120
Melander, H., Salmonson, T., Abadie, E., & van Zwieten-Boot, B. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.06.003 · Cited by 117
Rowe, M. A., McCrae, C. S., Campbell, J., Horne, C. H., Tiegs, T. J., Lehman, B., & Cheng, J. Q. (2008) · Behavioral Sleep Medicine · doi:10.1080/15402000801952872 · Cited by 105
Winkler, D., Pjrek, E., Praschak-Rieder, N., Willeit, M., Pezawas, L., Konstantinidis, A., Stastny, J., & Kasper, S. F. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.031 · Cited by 99
Self-citationSertraline 50 mg daily: the optimal dose in the treatment of depression
Preskorn, S., & Lane, R. M. (1995) · International Clinical Psychopharmacology · doi:10.1097/00004850-199510030-00001 · Cited by 90
Effects of Sertraline on Sleep Architecture in Patients With Depression
Jindal, R. D., Friedman, E. S., Berman, S. R., Fasiczka, A. L., Howland, R. H., & Thase, M. E. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000095345.32154.9a · Cited by 86
Zisapel, N., & Laudon, M. (2003) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.455 · Cited by 68
Santen, G., Gomeni, R., Danhof, M., & Pasqua, O. D. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.11.004 · Cited by 59
Psychopharmacological effects of sertraline in normal, healthy volunteers
Hindmarch, I., & Bhatti, J. Z. (1988) · European Journal of Clinical Pharmacology · doi:10.1007/bf00609258 · Cited by 58
Sleep estimation from wrist activity in patients with major depression
Jean‐Louis, G., Mendlowicz, M. V., Gillin, J. C., Rapaport, M. H., Kelsoe, J. R., Zizi, F., Landolt, H., & von Gizycki, H. (2000) · Physiology & Behavior · doi:10.1016/s0031-9384(00)00228-6 · Cited by 58
Rascati, K. L. (1995) · Clinical Therapeutics · doi:10.1016/0149-2918(95)80055-7 · Cited by 55
Daylight saving time transitions and hospital treatments due to accidents or manic episodes
Lahti, T. A., Haukka, J. K., Lönnqvist, J. K., & Partonen, T. (2008) · BMC Public Health · doi:10.1186/1471-2458-8-74 · Cited by 43
Saletu, B., & Grünberger, J. (1988) · PubMed · Cited by 42
Dodd, A., Hare, D. J., & Arshad, P. (2008) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2008.01063.x · Cited by 10
Fuchs, E., Schmelting, B., & Mocaër, E. (2006) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(06)70382-0 · Cited by 6
Cited by
Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease
Wulff, K., Gatti, S., Wettstein, J. G., & Foster, R. G. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2868 · Cited by 1,055
Self-citationAgomelatine, the first melatonergic antidepressant: discovery, characterization and development
de Bodinat, C., Guardiola-Lemaitre, B., Mocaër, E., Renard, P., Muñoz, C., & Millan, M. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3140 · Cited by 593
Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
Atkin, T., Comai, S., & Gobbi, G. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014381 · Cited by 391
Melatonin and its analogs in insomnia and depression
Cardinali, D. P., Srinivasan, V., Brzezinski, A., & Brown, G. M. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00962.x · Cited by 353
Novel melatonin-based therapies: potential advances in the treatment of major depression
Hickie, I. B., & Rogers, N. L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60095-0 · Cited by 334
Metadata
- Authors
- Kasper, S., Hajak, G., Wulff, K., Hoogendijk, W. J. G., Montejo, A. L., Smeraldi, E., Rybakowski, J. K., Quera-Salva, M.-A., Wirz-Justice, A. M., Picarel-Blanchot, F., & Baylé, F. J.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2010-02-15
- Volume
- 71
- Issue
- 02
- Pages
- 109-120
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2086546977
- Cited by
- 257
- References
- 50
- FWCI
- 22.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.